Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Return on Sales (2017 - 2025)

Historic Return on Sales for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to 9.68%.

  • Catheter Precision's Return on Sales rose 332400.0% to 9.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 26.33%, marking a year-over-year increase of 29600.0%. This contributed to the annual value of 39.63% for FY2024, which is 1200400.0% up from last year.
  • According to the latest figures from Q3 2025, Catheter Precision's Return on Sales is 9.68%, which was up 332400.0% from 34.71% recorded in Q2 2025.
  • Catheter Precision's 5-year Return on Sales high stood at 616.0% for Q3 2021, and its period low was 1918.93% during Q4 2022.
  • Its 5-year average for Return on Sales is 299.46%, with a median of 37.77% in 2024.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -20141900bps in 2022, then soared by 19137000bps in 2023.
  • Over the past 5 years, Catheter Precision's Return on Sales (Quarter) stood at 95.26% in 2021, then crashed by -2114bps to 1918.93% in 2022, then surged by 100bps to 5.23% in 2023, then plummeted by -623bps to 37.77% in 2024, then surged by 74bps to 9.68% in 2025.
  • Its Return on Sales stands at 9.68% for Q3 2025, versus 34.71% for Q2 2025 and 28.29% for Q1 2025.